Stay up to date with the latest news and milestones from our portfolio companies, as they continue to innovate and make an impact in the medtech world. From product launches and clinical achievements to strategic partnerships and industry recognition, discover how our startups are shaping the future of healthcare.
Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System
HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ — Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND™ Trans-Septal System for investigational device exemption (IDE) application to commence an Early Feasibility Study (EFS). The AMEND™ Trans-Septal System is a trans catheter [...]
Boston Scientific announces agreement to acquire SoniVie Ltd.
Acquisition to expand Interventional Cardiology Therapies offerings with ultrasound-based renal denervation therapy for treatment of hypertension MARLBOROUGH, Mass., March 3, 2025 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS™ [...]
LYMPHATICA MEDTECH CLOSES € 17.9 M SERIES B FUNDING ROUND TO DRIVE INNOVATION IN LYMPHEDEMA TREATMENT
Lausanne, October 8th, 2024 – Lymphatica Medtech SA, a clinical-stage company based in Lausanne, Switzerland, specialized in innovative treatments for lymphedema, has raised €17.9 million in Series B funding. This investment will accelerate the clinical development and validation of LymphoDrain, a breakthrough implantable device designed to treat lymphedema, a chronic vascular [...]
Nitinotes Appoints Lloyd Diamond as Chief Executive Officer
Experienced healthcare technology leader to drive company’s next phase of growth. CAESAREA, Israel, Aug. 19, 2024 /PRNewswire/ — Nitinotes, developers of EndoZip™, a fully automated endoscopic suturing system aimed at treating obesity, today announced the appointment of Lloyd Diamond as the Chief Executive Officer, effective immediately. Mr. Diamond brings more than 30 years of [...]
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
TAMPA, Fla., April 24, 2024 /PRNewswire/ — Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced a comprehensive corporate restructure by a group of investors led by Techwald Next, aimed at accelerating the company’s plans to initiate the AMEND mitral annuloplasty clinical studies in Europe and the United States. As part of the [...]
SentiAR Announces Close of $8.5 million Series B Financing
ST. LOUIS, April 11, 2023 /PRNewswire/ — SentiAR, Inc. a St. Louis, Missouri based pioneer in using Augmented Reality (AR) visualization technology for medical procedures, has closed an $8.5 million Series B financing. The financing was led by cultivate (MD) Ventures and joined by MedVenture Partners alongside several insider investors, including TechWald Holding, VCapital, QRM Capital, and Harmonix [...]
SoniVie Raises $60m in Round C Financing, and Appoints New Board Members
The funds, provided by new investors and current shareholder, will be used to support the Company clinical and regulatory path towards pre-market approval of its TIVUS™ technology for the treatment of hypertension TEL AVIV, Israel, Jan. 9, 2023 /PRNewswire/ — SoniVie Ltd. (“SoniVie” or the “Company”), a medical device company developing a proprietary solution [...]
Clinical experience with the Bendit steerable microcatheter: a new paradigm for endovascular treatment
Abstract Background Vessel tortuosity poses a challenge during endovascular treatment of neurovascular lesions. Bendit Technologies (Petah Tikva, Israel) has developed flexible, steerable microcatheters designed with unique bending and torquing capabilities. Objective To describe our first-in-human trial of Bendit21. Methods Bendit21 was used in our exploratory, prospective, multicenter, open-label, single-arm clinical study, and in [...]
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
TEL AVIV, Israel, July 13, 2022 /PRNewswire/ — SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS™) System to treat a variety of hypertensive disorders, announced that on May 30th 2022 the first patient was treated with its Renal Artery Denervation TIVUS™ technology, as part of the recently FDA IDE-approved Pilot [...]
SoniVie receives IDE approval from FDA for its Pilot study to treat Hypertension with its Renal Artery Denervation TIVUS™ technology
TEL AVIV, Israel, June 20, 2022 /PRNewswire/ — SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, announced that on May 5th 2022 the U.S. Food and Drug Administration granted IDE approval for its “REDUCED1” Pilot study to treat Resistant Hypertension Patients with Renal [...]
BENDIT Technologies Receives U.S. Food and Drug Administration 510(k) Clearance of its Bendit 021″ steerable microcatheter
TEL AVIV, Israel, April 18, 2022 /PRNewswire/ — BENDIT Technologies, a company focused on the development of a steerable microcatheter platform, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bendit21 microcatheter for treatment in the neuro, peripheral, and coronary vasculature. The clearance was received several [...]
Successful First-in-Human use of Bendit21 Neurovascular Catheter performed at the University of Texas Southwestern Medical Center
TEL AVIV, Israel, Jan. 20, 2022 /PRNewswire/ — BENDIT Technologies, a company focused on the development of steerable microcatheters, announced today the successful first use in the USA of the BENDIT21 neuro catheter in a life-saving treatment. The case involved a 57-year-old female patient who had been suffering for years from an inoperable symptomatic [...]